Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study

By Venkatachalam S   Bagratee JS   Moodley J  

Journal of Obstetrics & Gynaecology, Vol. 24, Iss. 7, 2004-10 ,pp. : 798-800

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the effects of the levonorgestrel-releasing intrauterine system (Mirena®) and depot-medroxyprogesterone acetate (Depo-Provera®) on subendometrial microvascularisation and uterine artery blood flow

By Dane Banu   Akca Aysu   Dane Cem   Evcimen Serap   Cetin Ahmet  

The European Journal of Contraception and Reproductive Health Care, Vol. 14, Iss. 3, 2009-06 ,pp. : 240-244

Informa Healthcare

Access to resources Recommend Favorite

Menstrual pattern and lipid profiles during use of medroxyprogesterone acetate and estradiol cypionate and NET-EN (200 mg) as contraceptive injections

By Canto de Cetina T.E.   Luna M.O.   Cetina Canto J.A.   Bassol S.  

Contraception, Vol. 69, Iss. 2, 2004-02 ,pp. : 115-119

Elsevier

Access to resources Recommend Favorite

Magnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraception

By Clark M.K.   Sowers M.   Levy B.T.   Tenhundfeld P.  

Fertility and Sterility, Vol. 75, Iss. 5, 2001-05 ,pp. : 871-877

Elsevier

Access to resources Recommend Favorite

Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate

By Pickar J.H.   Yeh I.-T.   Wheeler J.E.   Cunnane M.F.   Speroff L.  

Fertility and Sterility, Vol. 76, Iss. 1, 2001-07 ,pp. : 25-31

Elsevier

Access to resources Recommend Favorite